Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicament for treating chronic hepatitis B, cirrhosis and liver ascites

A technology for chronic hepatitis B and hepatic ascites, which is applied in drug combination, digestive system, and pharmaceutical formula, and can solve problems such as large side effects and unsatisfactory drug efficacy

Inactive Publication Date: 2010-12-29
李念
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, there are many drugs for treating diseases such as hepatitis B, liver cirrhosis and hepatic ascites, most of which are western medicines, but these drugs have relatively large side effects, and their efficacy is not satisfactory, and most patients are still suffering from pain
There is no specific drug for the treatment of hepatitis B and cirrhosis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0009] Example 1: 500 parts of Polygonum multiflorum, 250 parts of Angelica sinensis, 150 parts of Rhizoma Chuanxiong, 150 parts of Radix Paeoniae Alba, 150 parts of Atractylodes Rhizoma Rhizome, 150 parts of Coptis Rhizoma, 200 parts of Rehmannia glutinosa, 200 parts of Rehmannia glutinosa, 150 parts of Chicken Neijin, 150 parts of Divine Comedy, sealwort 150 parts, Perrin 150 parts, Polygonatum 150 parts, Corydalis 150 parts, Campanulaceae 150 parts, Gentiana 200 parts, Woody fragrance 150 parts, Green bark 150 parts, Lotus seeds 150 parts, Goji berry 200 parts, Plantago 150 parts, 250 parts of chrysanthemum, 150 parts of bupleurum, 500 parts of jujube, 150 parts of ginseng, 150 parts of licorice, 200 parts of skullcap.

[0010] The above raw materials can be crushed and mixed, and honey can be added according to conventional methods to make pills.

Embodiment 2

[0011] Example 2: 400 parts of Polygonum multiflorum, 200 parts of Angelica sinensis, 100 parts of Rhizoma Chuanxiong, 100 parts of Radix Paeoniae Alba, 100 parts of Atractylodes Rhizoma Rhizome, 100 parts of Coptidis Rhizoma, 100 parts of Rehmannia glutinosa, 150 parts of Rehmannia glutinosa, 100 parts of Chicken Neijin, 100 parts of Divine Comedy, sealwort 100 parts, Perrin 100 parts, Polygonatum 100 parts, Corydalis 100 parts, Campanulaceae 100 parts, Gentiana 150 parts, Woody fragrance 100 parts, Green bark 100 parts, Lotus seeds 100 parts, Lycium barbarum 150 parts, Plantago 100 parts, 200 parts of chrysanthemum, 100 parts of bupleurum, 400 parts of jujube, 100 parts of ginseng, 100 parts of licorice, and 150 parts of skullcap.

[0012] The above raw materials can be made into tablets according to conventional methods.

Embodiment 3

[0013] Example 3: 600 parts of Polygonum multiflorum, 300 parts of Angelica sinensis, 200 parts of Rhizoma Chuanxiong, 200 parts of Radix Paeoniae Alba, 200 parts of Atractylodes Rhizoma Rhizome, 200 parts of Coptis Rhizoma, 250 parts of Rehmannia glutinosa, 250 parts of Rehmannia glutinosa, 200 parts of Ji Nei Jin, 200 parts of Divine Comedy, sealwort 200 parts, Perrin 200 parts, Polygonatum 200 parts, Corydalis 200 parts, Campanulaceae 200 parts, Gentiana 250 parts, Woody fragrance 200 parts, Green bark 200 parts, Lotus seeds 200 parts, Lycium barbarum 250 parts, Plantago 200 parts, 300 parts of chrysanthemum, 200 parts of bupleurum, 600 parts of jujube, 200 parts of ginseng, 200 parts of licorice, 250 parts of skullcap.

[0014] The above raw materials can be made into decoction according to conventional methods.

[0015] The parts in the above embodiments are parts by weight.

[0016] The following are typical cases:

[0017] Case 1: Xu, female, 40 years old, from Zhumad...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a drug for treating chronic hepatitis B, liver cirrhosis and liver ascites, and the drug is prepared by the following pharmaceutical raw materials: tuber fleeceflower root, Chinese angelica, Szechuan lovage rhizome, white paeony root, largehead atractylodes rhizome, golden thread, dried rehmannia root, radix rehmanniae preparata, chicken's gizzard-membrane, medicated leaven, rhizome, fortune eupatorium herb, fragrant solomonseal rhizome, yanhusuo, platycodon root, Chinese gentian, costustoot, green tangerine peel, semen nelumbinis, barbary wolfberry fruit, plantain seed, chrysanthemum, Chinese thorowax root, Chinese date, coastal glehnia root, liquoric root and baical skullcap root. The various ingredients in the drug have reasonable compatibility, commonly play theeffects of invigorating spleen, replenishing qi, activating qi, easing depression, regulating qi-flowing for relieving pain, nourishing liver, dispersing stagnated liver qi, nourishing yin, supplementing blood, nourishing blood and invigorating spleen and kidney, treat both manifestation and root causes of the diseases and have good efficacy for the hepatitis B, the liver cirrhosis and the liver ascites, and the diseases can be radically cured by taking the drug according to the treatment course.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines and relates to a medicine for treating chronic hepatitis B, liver cirrhosis and hepatic ascites. Background technique [0002] Hepatitis B is a common disease, frequently-occurring disease, and also a stubborn disease. Viral hepatitis B is harmful, spreads widely, develops rapidly, and seriously endangers human health. In recent years, there have been relatively cutting-edge theoretical studies on the drugs and treatment methods for the treatment of liver fibrosis and cirrhosis after hepatitis B. According to modern medicine: through immunology, animal experiments, liver biopsy pathology, especially the use of cell, molecular and gene biology methods, it has been clarified that the pathogenesis of liver fibrosis after hepatitis B is due to the replication of hepatitis B virus in the body, causing The patient's immune system attacks his own liver cells, causing long-term infl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K35/37A61P31/20A61P1/16A61K36/8969A61K35/57
Inventor 李念
Owner 李念
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com